ALPHARETTA, Ga., Nov. 1 /PRNewswire/ -- Alliant Pharmaceuticals, Inc., a pediatric specialty pharmaceutical company, announced today the reformulation of RONDEC(R), a medication for cold and allergy symptoms. The reformulation replaces the antihistamine, pseudoephedrine, with phenylephrine. Four medications containing the RONDEC brand will be affected by the reformulation: RONDEC Syrup, RONDEC Oral Drops, RONDEC-DM Syrup and RONDEC-DM Oral Drops.
The RONDEC family is a single source product with no generic equivalent product available on the market. All old formulated RONDEC products containing pseudoephedrine will be discontinued and no longer available for use.
Mark Pugh, President of Alliant Pharmaceuticals, says reformulating the medications using phenylephrine has several advantages. "Phenylephrine is equally an efficacious decongestant as pseudoephedrine, and is less likely to give patients the jittery feeling that is often felt among pseudoephedrine users. With a pediatric patient, we feel this is a safer alternative."
Pseudoephedrine came under fire earlier this year as illegal drug users used pseudoephedrine to create crystal meth. At least 44 states have passed or are considering legislation to restrict products that contain pseudoephedrine. Over-the-counter medications containing pseudoephedrine are now placed behind the counter and dispensed by a pharmacist to those who are 18 years of age or older.
The reformulated RONDEC medications will be available beginning November 1, 2005.
About Alliant Pharmaceuticals, Inc.
Alliant Pharmaceuticals, Inc. is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products to pediatricians and pediatric specialty physicians. Alliant Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs. Additional information about Alliant Pharmaceuticals in available online at: http://www.alliantpharma.com.
Contact: Sharon Kraun 678.468.0064 skraun@bellsouth.net
Alliant Pharmaceuticals, Inc.CONTACT: Sharon Kraun, +1-678-468-0064, or skraun@bellsouth.net, forAlliant Pharmaceuticals, Inc.
Web site: http://www.alliantpharma.com/